Three-dimensional quantitative structure-activity relationships for a large series of potent antitubercular agents


Autoria(s): ANDRADE, Carolina Horta; SALUM, Livia de Barros; PASQUALOTO, Kerly Fernanda Mesquita; FERREIRA, Elizabeth Igne; ANDRICOPULO, Adriano Defini
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2008

Resumo

Comparative molecular field analysis (CoMFA) studies were conducted on a series of 100 isoniazid derivatives as anti-tuberculosis agents using two receptor-independent structural data set alignment strategies: (1) rigid-body fit, and (2) pharmacophore-based. Significant cross-validated correlation coefficients were obtained (CoMFA(1), q(2) = 0,75 and CoMFA(2), q(2) = 0.74), indicating the potential of the models for untested compounds. The models were then used to predict the inhibitory potency of 20 test set compounds that were not included in the training set, and the predicted values were in good agreement with the experimental results.

National Council for Scientific and Technological Development

National Council for Scientific and Technological Development

CNPq, Conselho Nacional de Pesquisa e Desenvolvimento

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

State of Sao Paulo Research Foundation (FAPESP, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo), Brazil

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Identificador

LETTERS IN DRUG DESIGN & DISCOVERY, v.5, n.6, p.377-387, 2008

1570-1808

http://producao.usp.br/handle/BDPI/30009

10.2174/157018008785777289

http://dx.doi.org/10.2174/157018008785777289

Idioma(s)

eng

Publicador

BENTHAM SCIENCE PUBL LTD

Relação

Letters in Drug Design & Discovery

Direitos

restrictedAccess

Copyright BENTHAM SCIENCE PUBL LTD

Palavras-Chave #tuberculosis #hydrazides #drug design #QSAR #CoMFA #Galahad #PHARMACOPHORE IDENTIFICATION #HOLOGRAM QSAR #TUBERCULOSIS #INHIBITORS #GALAHAD #DESIGN #3D #Chemistry, Medicinal
Tipo

article

original article

publishedVersion